>Mercado global de sistemas de soluciones de vigilancia de infecciones, por productos (software y servicios), tipo de infección (infecciones del sitio quirúrgico (SSI), infecciones del torrente sanguíneo (BSI), infecciones del tracto urinario (UTI), infecciones del torrente sanguíneo asociadas a la vía central (CLABSI), infección del tracto urinario asociada al catéter (CAUTI) y otras), usuario final (hospitales, centros de atención a largo plazo, clínicas, centros quirúrgicos ambulatorios, institutos académicos, otros), país (EE. UU., Canadá, México, Alemania, Italia, Reino Unido, Francia, España, Países Bajos, Bélgica, Suiza, Turquía, Rusia, Resto de Europa, Japón, China, India, Corea del Sur, Australia, Singapur, Malasia, Tailandia, Indonesia, Filipinas, Resto de Asia-Pacífico, Brasil, Argentina, Resto de Sudamérica, Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos, Egipto, Israel, Resto de Medio Oriente y África) Tendencias de la industria y pronóstico hasta 2028
Análisis y perspectivas del mercado: mercado global de sistemas de soluciones de vigilancia de infecciones
Se espera que el mercado de sistemas de soluciones de vigilancia de infecciones experimente un crecimiento del mercado a una tasa del 13,3% en el período de pronóstico de 2021 a 2028. El informe de investigación de mercado de Data Bridge sobre el mercado de sistemas de soluciones de vigilancia de infecciones proporciona análisis e información sobre los diversos factores que se espera que prevalezcan durante el período de pronóstico al tiempo que proporciona sus impactos en el crecimiento del mercado. El aumento de la prevalencia de infecciones asociadas a la atención médica (HAI) está intensificando el crecimiento del mercado de sistemas de soluciones de vigilancia de infecciones.
Los sistemas de vigilancia de infecciones se refieren al tipo de sistemas que se utilizan para monitorear y gestionar continuamente los datos de infecciones asociadas a la atención médica (IAAS) para la evaluación de la salud pública. Se dice que la detección temprana de enfermedades asegura una ejecución adecuada de las medidas preventivas.
El aumento de la resistencia de los microbios a los antibióticos y la alta adopción de la automatización en los entornos sanitarios actúan como los principales factores que impulsan el crecimiento del mercado de sistemas de soluciones de vigilancia de infecciones. El aumento de la incidencia de infecciones asociadas a los hospitales en un entorno clínico, incluidas las infecciones del tracto urinario, entre otras, las infecciones del sitio quirúrgico y la falta de saneamiento, aceleran el crecimiento del mercado de sistemas de soluciones de vigilancia de infecciones. El aumento de la tendencia a la automedicación, la mayor capacidad de los sistemas de TI para realizar el procesamiento analítico y el incumplimiento de la medicación prescrita influyen aún más en el mercado de sistemas de soluciones de vigilancia de infecciones. Además, las iniciativas gubernamentales en forma de políticas, el aumento del gasto sanitario, el aumento del número de cirugías y las actividades de investigación y desarrollo afectan positivamente al mercado de sistemas de soluciones de vigilancia de infecciones. Además, la integración de software basado en la nube y las economías emergentes amplían la oportunidad rentable a los actores del mercado de sistemas de soluciones de vigilancia de infecciones en el período de pronóstico de 2021 a 2028.
Por otro lado, el alto costo asociado con el software, la renuencia de los profesionales médicos a adoptar herramientas de atención médica avanzadas y la falta de profesionales de TI capacitados para operar actúan como los factores que se espera que obstaculicen el crecimiento del mercado de sistemas de soluciones de vigilancia de infecciones. Se proyecta que el aumento de la demanda de soluciones basadas en la web y plataformas móviles y la preferencia de los consumidores por la automatización en los centros de atención médica desafiarán el mercado de sistemas de soluciones de vigilancia de infecciones en el período de pronóstico de 2021 a 2028.
Este informe de mercado de sistemas de soluciones de vigilancia de infecciones proporciona detalles de nuevos desarrollos recientes, regulaciones comerciales, análisis de importación y exportación, análisis de producción, optimización de la cadena de valor, participación de mercado, impacto de los actores del mercado nacional y localizado, analiza oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado, análisis de crecimiento estratégico del mercado, tamaño del mercado, crecimientos del mercado de categorías, nichos de aplicación y dominio, aprobaciones de productos, lanzamientos de productos, expansiones geográficas, innovaciones tecnológicas en el mercado. Para obtener más información sobre el mercado de sistemas de soluciones de vigilancia de infecciones, comuníquese con Data Bridge Market Research para obtener un informe de analista, nuestro equipo lo ayudará a tomar una decisión de mercado informada para lograr el crecimiento del mercado.
Alcance y tamaño del mercado de los sistemas de soluciones de vigilancia de infecciones
El mercado de sistemas de soluciones de vigilancia de infecciones está segmentado en función de los productos, el tipo de infección y el usuario final. El crecimiento entre estos segmentos le ayudará a analizar los segmentos de crecimiento reducido en las industrias y brindará a los usuarios una valiosa descripción general del mercado.
- Sobre la base de los productos, el mercado de sistemas de soluciones de vigilancia de infecciones se segmenta en software y servicios.
- Sobre la base del tipo de infección, el mercado de sistemas de soluciones de vigilancia de infecciones se segmenta en infecciones del sitio quirúrgico (SSI), infecciones del torrente sanguíneo (BSI), infecciones del tracto urinario (UTI), infecciones del torrente sanguíneo asociadas a la línea central (CLABSI), infección del tracto urinario asociada al catéter (CAUTI) y otras.
- Sobre la base del usuario final, el mercado de sistemas de soluciones de vigilancia de infecciones está segmentado en hospitales , centros de atención a largo plazo, clínicas, centros quirúrgicos ambulatorios , institutos académicos y otros.
Análisis a nivel de país del mercado de sistemas de soluciones de vigilancia de infecciones globales
Se analiza el mercado de sistemas de soluciones de vigilancia de infecciones y se proporcionan información y tendencias del tamaño del mercado por país, productos, tipo de infección y usuario final como se menciona anteriormente.
The countries covered in the global infection surveillance solutions systems market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the infection surveillance solutions systems market because of the government initiative and rising incidence of HAIs in the U.S. and Canada. Asia-Pacific is expected to witness the significant growth during the forecast period of 2021 to 2028 because of the improving healthcare infrastructure and rising medical tourism in the region.
The country section of the infection surveillance solutions systems market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The infection surveillance solutions systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for infection surveillance solutions systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on infection surveillance solutions systems market. The data is available for historic period 2011-2019.
Competitive Landscape and Infection Surveillance Solutions Systems Market Share Analysis
The infection surveillance solutions systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to infection surveillance solutions systems market.
Los principales actores incluidos en el informe de mercado de sistemas de soluciones de vigilancia de infecciones son BD, Cerner Corporation, Illumina, Inc., RL Solutions, GOJO Industries, Inc., SC Johnson & Son, Inc., Baxter, Wolters Kluwer, Vigilanz Corporation, IBM Corporation, HyGreen Inc., Premier, Atlas MD, Deb Group Ltd, entre otros actores nacionales e internacionales. Los datos de participación de mercado están disponibles para todo el mundo, América del Norte, Europa, Asia-Pacífico (APAC), Oriente Medio y África (MEA) y América del Sur por separado. Los analistas de DBMR comprenden las fortalezas competitivas y brindan un análisis competitivo para cada competidor por separado.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR MARKET CHALLENGE MATRIX
2.9 DBMR VENDOR SHARE ANALYSIS
2.1 MULTIVARIATE MODELING
2.11 PRODUCTS LIFELINE CURVE
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING NUMBER OF HEALTHCARE-ACQUIRED INFECTIONS (HAIS)
3.1.2 INCREASING HEALTHCARE EXPENDITURE
3.1.3 GOVERNMENT POLICIES FOR PREVENTING HEALTH-ACQUIRED INFECTIONS (HAIS)
3.2 RESTRAINTS
3.2.1 HIGH COST OF SOFTWARE
3.2.2 DEARTH OF SKILLED IT PROFESSIONALS IN THE HEALTHCARE INDUSTRY
3.3 OPPORTUNITIES
3.3.1 CLOUD-BASED SOFTWARE OFFERS SIGNIFICANT GROWTH OPPORTUNITIES
3.3.2 HIGH GROWTH IN DEVELOPING COUNTRIES ACROSS ASIA-PACIFIC AND LATIN AMERICA
3.4 CHALLENGE
3.4.1 DATA SECURITY RISK
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS
6.1 OVERVIEW
6.2 SOFTWARE
6.2.1 WEB BASED
6.2.2 ON-PREMISE
6.3 SERVICES
6.3.1 TRAINING & CONSULTING SERVICES
6.3.2 IMPLEMENTATION SERVICES
6.3.3 PRODUCT SUPPORT & MAINTENANCE SERVICES
7 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE
7.1 OVERVIEW
7.2 SURGICAL SITE INFECTIONS (SSI)
7.3 URINARY TRACT INFECTIONS (UTI)
7.4 BLOOD STREAM INFECTIONS (BSI)
7.5 CENTRAL LINE-ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)
7.6 CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI)
7.7 OTHERS
8 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.2.1 LARGE HOSPITALS
8.2.2 MEDIUM-SIZED HOSPITALS
8.2.3 SMALL HOSPITALS
8.3 CLINICS
8.4 AMBULATORY SURGICAL CENTERS
8.5 LONG TERM CARE FACILITIES
8.5.1 NURSING HOMES
8.5.2 HOMECARE AGENCIES & SERVICES
8.5.3 ASSISTED LIVING FACILITIES
8.6 ACADEMIC INSTITUTES
8.7 OTHERS
9 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 U.K.
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 NETHERLANDS
9.3.7 SWITZERLAND
9.3.8 BELGIUM
9.3.9 RUSSIA
9.3.10 TURKEY
9.3.11 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 SOUTH KOREA
9.4.4 INDIA
9.4.5 AUSTRALIA
9.4.6 SINGAPORE
9.4.7 THAILAND
9.4.8 MALAYSIA
9.4.9 INDONESIA
9.4.10 PHILIPPINES
9.4.11 REST OF ASIA-PACIFIC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 REST OF SOUTH AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 SOUTH AFRICA
9.6.2 REST OF MIDDLE EAST & AFRICA
10 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EUROPE
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT ANALYSIS
11.1 DATA BRIDGE MARKET RESEARCH ANALYSIS
12 COMPANY PROFILES
12.1 WOLTERS KLUWER
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 BD
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 ILLUMINA, INC.
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 CERNER CORPORATION
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BAXTER
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 GOJO INDUSTRIES, INC.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENT
12.7 IBM CORPORATION
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENT
12.8 RL SOLUTIONS
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 S. C. JOHNSON & SON, INC.
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENT
12.1 VIGILANZ CORPORATION
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
13 CONCLUSION
14 QUESTIONNAIRE
15 RELATED REPORTS
Lista de Tablas
TABLE 1 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 2 GLOBAL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 3 GLOBAL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 4 GLOBAL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 5 GLOBAL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 7 GLOBAL SURGICAL SITE INFECTIONS (SSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET,BY REGION, 2017-2026 (USD MILLION)
TABLE 8 GLOBAL URINARY TRACT INFECTIONS (UTI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 9 GLOBAL BLOOD STREAM INFECTIONS (BSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 10 GLOBAL CENTRAL LINE-ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 GLOBAL CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 12 GLOBAL OTHERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 14 GLOBAL HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 GLOBAL HOSPITAL IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 16 GLOBAL CLINICS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 GLOBAL AMBULATORY SURGICAL CENTERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 18 GLOBAL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 GLOBAL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 20 GLOBAL ACADEMIC INSTITUTES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 GLOBAL OTHERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 22 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 24 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 25 NORTH AMERICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 26 NORTH AMERICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 27 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 28 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 29 NORTH AMERICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 30 NORTH AMERICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 31 U.S. SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 32 U.S. SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 33 U.S. SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 34 U.S. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 35 U.S. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 36 U.S. HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 37 U.S. LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 38 CANADA SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 39 CANADA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 40 CANADA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 41 CANADA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 42 CANADA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 43 CANADA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 44 CANADA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 45 MEXICO SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 46 MEXICO SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 47 MEXICO SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 48 MEXICO INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 49 MEXICO INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 50 MEXICO HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 51 MEXICO LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 52 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 53 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 54 EUROPE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 55 EUROPE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 56 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 57 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 58 EUROPE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 59 EUROPE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 60 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 61 GERMANY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 62 GERMANY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 63 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 64 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 65 GERMANY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 66 GERMANY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 67 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 68 FRANCE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 69 FRANCE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 70 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 71 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 72 FRANCE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 73 FRANCE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 74 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 75 U.K. SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 76 U.K. SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 77 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 78 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 79 U.K. HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 80 U.K. LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 81 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 82 ITALY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 83 ITALY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 84 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 85 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 86 ITALY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 87 ITALY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 88 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 89 SPAIN SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 90 SPAIN SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 91 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 92 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 93 SPAIN HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 94 SPAIN LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 95 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 96 NETHERLANDS SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 97 NETHERLANDS SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 98 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 99 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 100 NETHERLANDS HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 101 NETHERLANDS LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 102 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 103 SWITZERLAND SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 104 SWITZERLAND SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 105 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 106 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 107 SWITZERLAND HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 108 SWITZERLAND LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 109 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 110 BELGIUM SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 111 BELGIUM SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 112 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 113 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 114 BELGIUM HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 115 BELGIUM LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 116 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 117 RUSSIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 118 RUSSIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 119 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 120 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 121 RUSSIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 122 RUSSIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 123 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 124 TURKEY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 125 TURKEY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 126 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 127 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 128 TURKEY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 129 TURKEY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 130 REST OF EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 131 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 132 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 133 ASIA-PACIFIC SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 134 ASIA-PACIFIC SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 135 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 136 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 137 ASIA-PACIFIC HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 138 ASIA-PACIFIC LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 139 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 140 CHINA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 141 CHINA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 142 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 143 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 144 CHINA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 145 CHINA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 146 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 147 JAPAN SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 148 JAPAN SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 149 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 150 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 151 JAPAN HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 152 JAPAN LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 153 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 154 SOUTH KOREA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 155 SOUTH KOREA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 156 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 157 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 158 SOUTH KOREA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 159 SOUTH KOREA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 160 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 161 INDIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 162 INDIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 163 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 164 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 165 INDIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 166 INDIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 167 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 168 AUSTRALIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 169 AUSTRALIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 170 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 171 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 172 AUSTRALIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 173 AUSTRALIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 174 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 175 SINGAPORE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 176 SINGAPORE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 177 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 178 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 179 SINGAPORE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 180 SINGAPORE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 181 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 182 THAILAND SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 183 THAILAND SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 184 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 185 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 186 THAILAND HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 187 THAILAND LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 188 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 189 MALAYSIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 190 MALAYSIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 191 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 192 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 193 MALAYSIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 194 MALAYSIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 195 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 196 INDONESIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 197 INDONESIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 198 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 199 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 200 INDONESIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 201 INDONESIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 202 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 203 PHILIPPINES SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 204 PHILIPPINES SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 205 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 206 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 207 PHILIPPINES HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 208 PHILIPPINES LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 209 REST OF ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 210 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 211 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 212 SOUTH AMERICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 213 SOUTH AMERICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 214 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 215 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 216 SOUTH AMERICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 217 SOUTH AMERICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 218 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 219 BRAZIL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 220 BRAZIL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 221 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 222 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 223 BRAZIL HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 224 BRAZIL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 225 REST OF SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 226 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 227 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 228 MIDDLE EAST AND AFRICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 229 MIDDLE EAST AND AFRICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 230 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 231 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 232 MIDDLE EAST AND AFRICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 233 MIDDLE EAST AND AFRICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 234 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 235 SOUTH AFRICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 236 SOUTH AFRICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 237 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 238 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 239 SOUTH AFRICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 240 SOUTH AFRICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 241 REST OF MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
Lista de figuras
FIGURE 1 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SEGMENTATION
FIGURE 2 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DATA VALIDATION MODEL
FIGURE 3 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: GLOBAL VS REGIONAL ANALYSIS
FIGURE 5 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 9 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE OF THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET
FIGURE 11 HEALTHCARE EXPENDITURE IN FEW COUNTRIES (2015 & 2016)
FIGURE 12 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SEGMENTATION
FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 14 INCREASING NUMBER OF HEALTHCARE-ACQUIRED INFECTIONS (HAIS) AND INCREASING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 15 SOFTWARE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN 2019 & 2026
FIGURE 16 NORTH AMERICA IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 17 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS, 2018
FIGURE 18 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY INFECTION TYPE, 2018
FIGURE 19 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY END USER, 2018
FIGURE 20 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 21 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2018)
FIGURE 22 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2019 & 2026)
FIGURE 23 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2018 & 2026)
FIGURE 24 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 25 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 26 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 27 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 28 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 29 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 30 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 31 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 32 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 33 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 34 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 35 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 36 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 37 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 38 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 39 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 40 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 41 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 42 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 43 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 44 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 45 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 46 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 47 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 48 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 49 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 50 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
FIGURE 51 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
FIGURE 52 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
FIGURE 53 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
